White House again weighs in with US high court on ‘skinny label’ infringement
With the US solicitor general urging the Supreme Court this month to grant certiorari in Hikma Pharmaceuticals’ appeal of an induced infringement verdict over a generic drug’s “skinny label,” both US...To view the full article, register now.
Already a subscriber? Click here to view full article